-
That the arteriovenous fistula (AVF) is the lifeline for hemodialysis is a well-worn but well deserved cliché. The AVF has been a trusted vascular access for the last 55 years. Apart from allowing an individual on [read more...] -
Chimeric antigen receptor T-cell (CAR-T) therapy is a type of treatment in which a patient’s T cells are changed in the laboratory so they will attack cancer cells. T cells are first taken from a patient’s blood. [read more...] -
PathPointers highlight important everyday teaching points when reviewing kidney histology. These brief and easy-to-read blog posts include real clinical images to demonstrate various biopsy findings. When it comes to plasma [read more...] -
Introduction I used to think that if I studied physiology enough. If I developed a sophisticated model of how the body works, I could use it to recognize and respond to disease by choosing therapies that “made sense” to [read more...] -
The coronavirus (SARS-CoV-2) pandemic of 2019 is an unparalleled time in our history with an unprecedented strain on the US healthcare system, particularly in terms of resources available for patients requiring kidney [read more...]
September 2020
Atlas of Renal Pathology II
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 4
-
Atlas of Renal Pathology IIAcute and Chronic Antibody-Mediated Rejection Represent a Continuum of Endothelial Injury Involving Multiple Immune Mechanisms
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 5
-
Atlas of Renal Pathology IIAtlas: Clinical Quiz 1
-
Atlas of Renal Pathology IIAJKD Atlas of Renal Pathology: Cholesterol Emboli
-
Atlas of Renal Pathology IIRecurrent and De Novo FSGS Following Kidney Transplantation
-
Atlas of Renal Pathology IIRecurrent and De novo Posttransplant Minimal Change Disease
-
Atlas of Renal Pathology IIFocal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology IIRenal Amyloidosis – What We Need to Consider, Practical Tips
-
Atlas of Renal Pathology IIDiffuse Mesangial Sclerosis
